AWM
MRNA icon

Avondale Wealth Management’s Moderna MRNA Stock Holding History

Avondale Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-660
Closed -$168K – 125
2021
Q4 		$168K Buy
+660
New +$193K 0.17% 46
2021
Q2 		– Sell
-3,200
Closed -$419K – 105
2021
Q1 		$419K Buy
3,200
+3,000
+1,500% +$435K 0.41% 28
2020
Q4 		$21K Sell
200
-416
-68% -$42.1K 0.02% 81
2020
Q3 		$44K Buy
+616
New +$42.9K 0.07% 48

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Avondale Wealth Management's MRNA Position: Q1 2022 in Review

Avondale Wealth Management sold out of Moderna (MRNA) in Q1 2022, closing a stake of 660 shares — an estimated $168K sold.

Avondale Wealth Management first reported a position in MRNA in Q3 2020 and held it in 4 quarters. The position peaked at $419K in Q1 2021. 1,006 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • Avondale Wealth Management reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
  • Avondale Wealth Management sold 660 Moderna shares in Q1 2022, an estimated $168K.
  • Avondale Wealth Management first reported a position in Moderna in Q3 2020 and held it in 4 quarters.
  • Avondale Wealth Management's Moderna position peaked at $419K in Q1 2021.
  • 1,006 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on Avondale Wealth Management's 13F filing for Q1 2022, filed 12 Apr 2022.